Company Filing History:
Years Active: 2016-2018
Title: Ian Alexander Mcdonald: Innovator in Pharmaceutical Chemistry
Introduction
Ian Alexander Mcdonald is a notable inventor based in New South Wales, Australia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical use. With a total of 3 patents to his name, Mcdonald's work focuses on addressing various health conditions through novel therapeutic agents.
Latest Patents
One of Mcdonald's latest patents is titled "Substituted 3-haloallylamine inhibitors of SSAO and uses thereof." This invention pertains to the preparation and pharmaceutical application of substituted 3-haloallylamine derivatives as SSAO/VAP-1 inhibitors. The compounds are designed to treat a range of conditions, including inflammatory diseases, ocular diseases, fibrotic diseases, diabetes-induced diseases, and cancer. The patent outlines methods for utilizing these compounds, or their pharmaceutically acceptable salts or derivatives, for effective treatment.
Career Highlights
Ian Alexander Mcdonald is currently associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role involves research and development of innovative therapeutic solutions that can significantly impact patient care and treatment outcomes.
Collaborations
Throughout his career, Mcdonald has collaborated with esteemed colleagues, including Mandar Deodhar and Alison Dorothy Findlay. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in pharmaceutical chemistry.
Conclusion
Ian Alexander Mcdonald stands out as a prominent inventor in the pharmaceutical industry, with a focus on developing effective treatments for various diseases. His contributions through patents and collaborations continue to advance the field and improve health outcomes for patients worldwide.